INS and atherosclerosis: Since adiponectin increases cellular sensitivity to insulin [37, 125–127] and also possesses anti-atherogenic effects [128–130], a marked reduction in the circulatory concentrations of adiponectin results in IR and atherosclerosis via systemic inflammation [115].